Target intelligence / Profile preview

RN7SK pseudogene 64 (RN7SKP64)

Target
RN7SKP64
Molecular classification
Pseudogene, Non-coding RNA derivative
01

Overview

RN7SK pseudogene 64 (RN7SKP64) is classified as a *pseudogene*—a DNA sequence similar to the functional 7SK small nuclear RNA (snRNA) gene but that does not produce a functional product. Unlike the canonical 7SK snRNA, which is an evolutionary conserved, abundant small non-coding RNA important for regulating transcription elongation in metazoans via sequestration and inhibition of the P-TEFb transcription factor complex, RN7SKP64 is not known to be transcribed or, if transcribed, not functional. There is no evidence that RN7SKP64 has a biological function, or any relevance as a receptor, enzyme, transporter, signaling molecule, or therapeutic target. It is important to distinguish this pseudogene from the bona fide RN7SK gene, which encodes functional 7SK RNA with well described regulatory roles in transcription. Key Considerations: - RN7SKP64 is not a therapeutic target, and there is no evidence it interacts with drugs or is relevant to disease roles, biological functions, or mechanism of action in any established sense. - The functional 7SK snRNA is not a protein, receptor, or canonical drug target but a regulatory non-coding RNA. - Listings of RN7SKP64 in genetic databases reflect genomic annotation only; it is not a functional gene. Summary: RN7SKP64 is a pseudogene with no evidence for transcription, protein coding, or biological function, and should not be considered a molecular target for therapy or research except as a genomic marker. If seeking functional RNA, refer to "7SK small nuclear RNA" (gene symbol RN7SK), not RN7SKP64.

Other names
RNA, 7SK small nuclear pseudogene 64RN7SKP64

Beyond the preview

Go deeper on RN7SK pseudogene 64 (RN7SKP64).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 64 (RN7SKP64).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call